Peter Damsbo
Technik-/Wissenschafts-/F&E-Leiter bei Coegin Pharma AS
Profil
Peter Damsbo is currently the Chief Medical Officer at Coegin Pharma.
AS since 2010 and a Partner at Ventac Partners GmbH since 2009.
He previously worked as the Medical Director-Diabetes at Novo Nordisk A from 2011 to 2012, and at Novo Nordisk, Inc. as a Medical Director-Diabetes.
He also served as the Chief Medical Officer at Zealand Pharma A and as a Research Fellow at Steno Diabetes Center A.
Dr. Damsbo holds a doctorate degree from the University of Copenhagen.
Aktive Positionen von Peter Damsbo
| Unternehmen | Position | Beginn |
|---|---|---|
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Technik-/Wissenschafts-/F&E-Leiter | 06.04.2010 |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01.06.2009 |
Ehemalige bekannte Positionen von Peter Damsbo
| Unternehmen | Position | Ende |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
| Steno Diabetes Center A/S | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Peter Damsbo
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Health Technology |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Commercial Services |
| Steno Diabetes Center A/S | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
